Roles of osteoclasts in alveolar bone remodeling

被引:65
作者
Omi, Maiko [1 ]
Mishina, Yuji [1 ]
机构
[1] Univ Michigan, Sch Dent, Dept Biol & Mat Sci & Prosthodont, 4228 Dent,1011 N Univ Ave, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
alveolar bone; bone remodeling; bone resorption; jawbone; mechanical stress; osteoclast; periodontitis; KAPPA-B LIGAND; MEDICATION-RELATED OSTEONECROSIS; PERIODONTAL-LIGAMENT CELLS; ORTHOPEDIC WEAR PARTICLES; RECEPTOR ACTIVATOR; RANKL EXPRESSION; GENE-EXPRESSION; TOOTH MOVEMENT; CATHEPSIN K; MECHANICAL FORCE;
D O I
10.1002/dvg.23490
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osteoclasts are large multinucleated cells from hematopoietic origin and are responsible for bone resorption. A balance between osteoclastic bone resorption and osteoblastic bone formation is critical to maintain bone homeostasis. The alveolar bone, also called the alveolar process, is the part of the jawbone that holds the teeth and supports oral functions. It differs from other skeletal bones in several aspects: its embryonic cellular origin, the form of ossification, and the presence of teeth and periodontal tissues; hence, understanding the unique characteristic of the alveolar bone remodeling is important to maintain oral homeostasis. Excessive osteoclastic bone resorption is one of the prominent features of bone diseases in the jaw such as periodontitis. Therefore, inhibiting osteoclast formation and bone resorptive process has been the target of therapeutic intervention. Understanding the mechanisms of osteoclastic bone resorption is critical for the effective treatment of bone diseases in the jaw. In this review, we discuss basic principles of alveolar bone remodeling with a specific focus on the osteoclastic bone resorptive process and its unique functions in the alveolar bone. Lastly, we provide perspectives on osteoclast-targeted therapies and regenerative approaches associated with bone diseases in the jaw.
引用
收藏
页数:18
相关论文
共 198 条
[1]   A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants [J].
Abtahi, Jahan ;
Tengvall, Pentti ;
Aspenberg, Per .
BONE, 2012, 50 (05) :1148-1151
[2]   Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss [J].
Aguirre, JI ;
Plotkin, LI ;
Stewart, SA ;
Weinstein, RS ;
Parfitt, AM ;
Manolagas, SC ;
Bellido, T .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (04) :605-615
[3]   Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review [J].
Akram, Zohaib ;
Abduljabbar, Tariq ;
Kellesarian, Sergio Varela ;
Abu Hassan, Mohamed Ibrahim ;
Javed, Fawad ;
Vohra, Fahim .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (03) :444-454
[4]   NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism [J].
Aliprantis, Antonios O. ;
Ueki, Yasuyoshi ;
Sulyanto, Rosalyn ;
Park, Arnold ;
Sigrist, Kirsten S. ;
Sharma, Sudarshana M. ;
Ostrowski, Michael C. ;
Olsen, Bjorn R. ;
Glimcher, Laurie H. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (11) :3775-3789
[5]   Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling [J].
AlQranei, Mohammed S. ;
Senbanjo, Linda T. ;
Aljohani, Hanan ;
Hamza, Therwa ;
Chellaiah, Meenakshi A. .
BMC IMMUNOLOGY, 2021, 22 (01)
[6]   Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors [J].
Arai, F ;
Miyamoto, T ;
Ohneda, O ;
Inada, T ;
Sudo, T ;
Brasel, K ;
Miyata, T ;
Anderson, DM ;
Suda, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1741-1754
[7]   Added effect of 1% topical alendronate in intra-bony and inter-radicular defects as part of step II periodontal therapy: a systematic review with meta-analysis and trial sequential analysis [J].
Arena, Claudia ;
Caponio, Vito Carlo Alberto ;
Zhurakivska, Khrystyna ;
Lo Russo, Lucio ;
Lo Muzio, Lorenzo ;
Troiano, Giuseppe .
BMC ORAL HEALTH, 2022, 22 (01)
[8]  
Assenza Bartolomeo, 2003, J Oral Implantol, V29, P1, DOI 10.1563/1548-1336(2003)029<0001:OAALAU>2.3.CO
[9]  
2
[10]   The underlying pathophysiology and therapeutic approaches for osteoporosis [J].
Awasthi, Harshika ;
Mani, Dayanandan ;
Singh, Divya ;
Gupta, Atul .
MEDICINAL RESEARCH REVIEWS, 2018, 38 (06) :2024-2057